EP-A1- 2 111 869 (B1)

GARDAI S J ET AL: "Cell-surface calreticulin initiates clearance of viable apoptotic cells through trans-activation of LRP on the phagocyte", CELL, ELSEVIER, AMSTERDAM NL, vol. 123, 21 October 2005 (2005-10-21), pages 321-334, XP002432361, ISSN: 0092-8674, DOI: 10.1016/J.CELL.2005.08.032 (B1)

JAISWAL SIDDHARTHA ET AL: "CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis", CELL, CELL PRESS, US, vol. 138, no. 2, 1 July 2009 (2009-07-01), pages 271-285, XP009160236, ISSN: 0092-8674, DOI: 10.1016/J.CELL.2009.05.046 (B1)

US-A1- 2004 213 792 (B1)

M. JAN ET AL: "Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell marker", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 108, no. 12, 7 March 2011 (2011-03-07), pages 5009-5014, XP055029836, ISSN: 0027-8424, DOI: 10.1073/pnas.1100551108 (B1)

Per-Arne Oldenborg et al: "Cd47-Signal Regulatory Protein (Sirpa) Regulates Fc-gamma and Complement Receptor-Mediated Phagocytosis", The Journal of Experimental Medicine, vol.193, no. 7, 2 April 2001 (2001-04-02), pages 855-861, XP055283803, Retrieved from the Internet: URL:http://www.ncbi.nlm.nih.gov/pmc/articl es/PMC2193364/pdf/010027.pdf [retrieved on 2016-06-27] (B1)

RAVINDRA MAJETI ET AL: "CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells", CELL, vol. 138, no. 2, 1 July 2009 (2009-07-01), pages 286-299, XP055277135, US ISSN: 0092-8674, DOI: 10.1016/j.cell.2009.05.045 (B1)

JAMIESON C ET AL: "Increased expression of CD47 is a constant marker in mouse and human myeloid leukemias", BLOOD, AMERICAN SOCIETY OF HEMATOLOGY, US, vol. 106, 1 January 2005 (2005-01-01), page 911A, XP008138745, ISSN: 0006-4971 (B1)